Open Access
Reversal of Profound Rocuronium-induced Blockade with Sugammadex
AnesthesiologyPeer ReviewedR Kevin Jones +32008Journals
Traditionally, reversal of nondepolarizing neuromuscular blocking agents was achieved using acetylcholinesterase inhibitors, but these are unable to adequately reverse profound blockade. Sugammadex is a novel reversal agent, reversing the effects of rocuronium by encapsulation. This study assessed the efficacy and safety of sugammadex versus neostigmine for reversal of profound rocuronium-induced neuromuscular blockade.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support